Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM4 | Q14833 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27999703 | 0.85 | — | — | |
| SCHEMBL17291846 | 0.78 | GRM4 (0.30) | GRM4 | |
| SCHEMBL28609429 | 0.78 | — | — | |
| SCHEMBL20420817 | 0.78 | HSD11B1 (0.41) | GRM4 | |
| SCHEMBL11131364 | 0.78 | — | — | |
| SCHEMBL2543218 | 0.73 | POLB (0.34) | — | |
| SCHEMBL18833223 | 0.73 | — | — | |
| SCHEMBL4232200 | 0.70 | — | — | |
| SCHEMBL4586267 | 0.70 | TP53 (0.30) | — | |
| SCHEMBL8813225 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120136219-A | Janus structure wood-based solar water and electricity cogeneration evaporator based on metal organic framework modification and preparation method thereof | 东北林业大学 | 2025-06-13 | — | — | CN | claimed |
| CN-119505170-A | Preparation method and application of porous organic polymer adsorbent | 天津大学 | 2025-02-25 | — | — | CN | claimed |
| WO-1993008231-A1 | POLYMER BLENDS | THE BRITISH PETROLEUM COMPANY PLC (GB) | 1993-04-29 | — | — | WO | claimed |
| US-12551519-B2 | Extraction system and method for organic metabolites | VCENNA TECH & LABS INC (CA) | 2026-02-17 | — | — | US | disclosed |
| US-12522413-B2 | Gas barrier laminate, and gas barrier packaging material and pillow packaging bag formed of the laminate | DAI NIPPON PRINTING CO., LTD. (JP) | 2026-01-13 | — | — | US | disclosed |
| CN-120136219-A | Janus structure wood-based solar water and electricity cogeneration evaporator based on metal organic framework modification and preparation method thereof | 东北林业大学 | 2025-06-13 | — | — | CN | disclosed |
| CN-118638707-B | Corynebacterium glutamicum with high yield of exendin and application thereof | 杭州佳嘉乐生物技术有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119505170-A | Preparation method and application of porous organic polymer adsorbent | 天津大学 | 2025-02-25 | — | — | CN | disclosed |
| CN-118696032-A | Olaparib hydroxybenzoic acid co-crystal and pharmaceutical application thereof | 努福米克斯技术有限公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-118638707-A | Corynebacterium glutamicum with high yield of exendin and application thereof | 杭州佳嘉乐生物技术有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-112074599-B | Transformant of coryneform bacterium and method for producing useful compound using same | 公益财团法人地球环境产业技术研究机构 | 2024-09-03 | — | — | CN | disclosed |
| EP-2008095-A1 | FUNCTIONAL METHOD TO IDENTIFY TASTANTS | Givaudan SA (CH) | 2008-12-31 | — | — | EP | disclosed |
| EP-1930002-A1 | USE OF HYDROXYBENZOIC ACID ESTER AND ANALOGUES FOR THE MANUFACTURE OF A MENDICAMENT FOR THE PREVENTION AND TREATMENT OF VIRUS INFECTION | SHENGHUA (GUANGZHOU) PHARMACEUTICAL SCIENCE & (CN) | 2008-06-11 | — | — | EP | disclosed |
| US-20080119550-A1 | Use of e.g. 2,4-dihydroxybenzoic acid or 3,4,5-trihydroxybenzoic acid or esters thereof; hepatitis B virus (HBV), papillomavirus and/or herpes virus | SHENGHUA GUANGZHOU PHARMACEUTICAL SCIENCE & TECHNOLOGY CO., LTD. (CN) | 2008-05-22 | — | — | US | disclosed |
| EP-1581555-B1 | CHIMERIC ALPHA Q-GUSTDUCIN G-PROTEINS | GIVAUDAN SA (CH) | 2008-04-30 | — | — | EP | disclosed |
| WO-2007121600-A1 | NUCLEIC ACID, POLYPEPTIDE AND ITS USE | GIVAUDAN SA (CH) | 2007-11-01 | — | — | WO | disclosed |
| WO-2007121599-A1 | FUNCTIONAL METHOD TO IDENTIFY TASTANTS | GIVAUDAN SA (CH) | 2007-11-01 | — | — | WO | disclosed |
| US-20060275765-A1 | G-proteins | GIVAUDAN SA (CH) | 2006-12-07 | — | — | US | disclosed |
| EP-1581555-A2 | G-PROTEINS | Givaudan SA (CH) | 2005-10-05 | — | — | EP | disclosed |
| WO-2004055048-A2 | CHIMERIC ALPHA Q-GUSTDUCIN G-PROTEINS | GIVAUDAN SA (CH) | 2004-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119550-A1 | Use of e.g. 2,4-dihydroxybenzoic acid or 3,4,5-trihydroxybenzoic acid or esters thereof; hepatitis B virus (HBV), papillomavirus and/or herpes virus | ETV1, ETV6, CYP8B1 | GRM4 1496/4885 |
| US-12551519-B2 | Extraction system and method for organic metabolites | SHH, WNT1, WNT3A | GRM4 1890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.